FTSE 100
10.233,07
PKT
-43,88
PKT
-0,43
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.03.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 16.03.17 | Unilever Sell | Goldman Sachs Group Inc. | |
| 16.03.17 | Unilever Sell | Goldman Sachs Group Inc. | |
| 15.03.17 | Prudential Conviction Buy | Goldman Sachs Group Inc. | |
| 15.03.17 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 15.03.17 | Shell (ex Royal Dutch Shell) overweight | Morgan Stanley | |
| 15.03.17 | BP overweight | Morgan Stanley | |
| 15.03.17 | Unilever buy | Jefferies & Company Inc. | |
| 15.03.17 | Unilever buy | Jefferies & Company Inc. | |
| 15.03.17 | Prudential Underweight | JP Morgan Chase & Co. | |
| 15.03.17 | BP overweight | JP Morgan Chase & Co. | |
| 15.03.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 15.03.17 | AstraZeneca buy | Deutsche Bank AG | |
| 15.03.17 | Rio Tinto Outperform | Robert W. Baird & Co. Incorporated | |
| 14.03.17 | Rio Tinto Equal-Weight | Morgan Stanley | |
| 14.03.17 | Prudential Hold | S&P Capital IQ | |
| 14.03.17 | Prudential buy | UBS AG | |
| 14.03.17 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 14.03.17 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 14.03.17 | London Stock Exchange (LSE) buy | Citigroup Corp. | |
| 14.03.17 | Barclays Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | HSBC Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 13.03.17 | BT Group Neutral | JP Morgan Chase & Co. | |
| 13.03.17 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 13.03.17 | BT Group Neutral | Goldman Sachs Group Inc. | |
| 13.03.17 | Shell (ex Royal Dutch Shell) Outperform | Robert W. Baird & Co. Incorporated | |
| 10.03.17 | National Grid Hold | Deutsche Bank AG | |
| 10.03.17 | BT Group Neutral | UBS AG | |
| 10.03.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 10.03.17 | BP overweight | JP Morgan Chase & Co. | |
| 10.03.17 | Diageo Outperform | BNP PARIBAS | |
| 09.03.17 | GSK buy | Jefferies & Company Inc. | |
| 09.03.17 | AstraZeneca buy | Jefferies & Company Inc. | |
| 09.03.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 09.03.17 | GSK Reduce | Kepler Cheuvreux | |
| 09.03.17 | Vodafone Group Underperform | Macquarie Research | |
| 08.03.17 | GSK Neutral | UBS AG | |
| 08.03.17 | Lloyds Banking Group Hold | Deutsche Bank AG | |
| 08.03.17 | GSK Equal weight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.